-
According to an industry expert, the company is liable to pay compensation to people in case of serious side effects caused by the vaccine administered while in the clinical trial mode
-
Transport Minister Puvvada Ajay Kumar along with MP Nama Nageswar Rao has formally launched the vaccination programme at the District Hospital.
-
Krishnamma, a sanitation worker at Gandhi Hospital was the first person to receive the Covid vaccine in Telangana.
-
The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination, wrote the doctors
-
Addressing the country digitally, the Prime Minister said that India managed to make two 'Made-in-India' vaccines in a very short period which usually takes years.
-
So far, the government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.
-
"I am happy and excited that I received the much-awaited vaccine. I am feeling well," said Biranchi Nayak, the sanitary worker.
-
The world's biggest vaccination drives comes almost a year after the first coronavirus case was detected in India, which then claimed over 1.5 lakh lives and infected one crore people.
-
58 healthcare centres ready to provide emergency services to individuals with Adverse Events Following Immunisation across State
-
The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India
-
Modi to launch nationwide drive through video link; 4,000 TS health staff to get inoculated at 139 centres on Day 1
-
A total of 14 centres have been identified for vaccination in Karimnagar, Jagitial, Peddapalli and Rajanna-Sircilla districts on the first day of vaccination process from Saturday
-
The list of AEFI for Covishield include injection site tenderness, injection site pain, headache fatigue, myalgia, malaise, pyrexia, chills and arthralgia nausea
-
After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru
-
"Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible"
-
The supplies of Covaxin will be prioritised for public market through direct procurement by Brazil government while the supplies to private market would be based upon receipt of market authorisation from the country's regulator
-
Suggests advance arrangements be made to provide medical treatment if one develops a reaction
-
New Delhi: The much-anticipated inoculation programme against Covid-19 in the country is expected to begin by January 12, said government sources. “In all likelihood, the Covid immunisation drive is expected to start early next week. Considering the preparations, the roll-out programme may start on January 11 or latest by January 12,” a senior government official […]
-
The Drugs Controller General of India on Sunday gave the permission to Bharat Biotech's Covaxin for use in an emergency situation.
-
The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data